Clinical Trials Browser

Phase 4 × trastuzumab deruxtecan × Clear all

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Phase 4 Recruiting

Brain Neoplasms, Breast Neoplasms

NCT06429761 2025-11-24

STRIDE

Phase 4 Recruiting

Breast Neoplasms

NCT06245824 2024-02-07

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Phase 4 Not yet recruiting

Breast Neoplasms